Iwasaki Akinori, Hamanaka Wakako, Harnada Toshinori, Maekawa Shinichi, Enatsu Sotarou, Shirakusa Takayuki
Department of Thoracic Surgery, School of Medicine, Fukuoka University, 45-1, 7-chome Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.
Int Surg. 2007 Mar-Apr;92(2):103-9.
Many studies have asserted that thrombocytosis has a prognostic impact in various malignancies. To date, there has been no report of platelet value in patients with pulmonary metastasis. We retrospectively reviewed the medical charts of 143 patients with resection for lung metastasis. The thrombocyte cut-off was 22 x 10(4) /ml, which was the average count in this study, and we separated patients into two groups (high group versus low group). Cases of larger-size (>2-0.5 cm) pulmonary metastasis showed a significant increase compared with cases of smaller size (-2 cm; P = 0.0040). In univariate analysis, location in the bilateral lung and higher platelet count were significantly associated with prognosis. Multivariate analysis showed that only the high platelet group (P = 0.0334) showed significant independent prognostic factors. Platelet count may be a valuable marker in patients with pulmonary metastasis and for surgical indication with higher count.
许多研究断言,血小板增多症在各种恶性肿瘤中具有预后影响。迄今为止,尚无关于肺转移患者血小板值的报告。我们回顾性分析了143例肺转移切除术患者的病历。血小板临界值为22×10⁴/ml,这是本研究中的平均计数,我们将患者分为两组(高组与低组)。较大尺寸(>2 - 0.5 cm)肺转移病例与较小尺寸(≤2 cm)病例相比有显著增加(P = 0.0040)。单因素分析显示,双侧肺转移和较高的血小板计数与预后显著相关。多因素分析表明,只有高血小板组(P = 0.0334)显示出显著的独立预后因素。血小板计数可能是肺转移患者以及血小板计数较高时手术指征的一个有价值的标志物。